<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02207140</url>
  </required_header>
  <id_info>
    <org_study_id>DKID H-1-2014-051</org_study_id>
    <secondary_id>H-1-2014-051</secondary_id>
    <nct_id>NCT02207140</nct_id>
  </id_info>
  <brief_title>Effect of Multi-species Probiotic HOWARU® Restore, on Gut Microbiota of Elderly</brief_title>
  <official_title>Effect of Multi-species Probiotic HOWARU® Restore, on Gut Microbiota of Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gabriella C. van Zanten</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is randomized, double-blinded and placebo-controlled with a duration of 24 weeks.&#xD;
      Following randomization, healthy elderly are randomized into two groups receiving probiotics&#xD;
      or placebo. Fecal samples are collected before and after the study. The samples are&#xD;
      investigated for Clostridium difficile levels, changes in diversity of the gut microbiota as&#xD;
      well changes in the fecal metabolome. The effects of the produced metabolites on&#xD;
      mitochondrial activity will moreover be investigated using selected intestinal cell lines.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fecal Clostridium difficile numbers</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>fecal microbial composition</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>fecal metabolome</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Elderly</condition>
  <condition>Probiotics</condition>
  <condition>Clostridium Difficile</condition>
  <condition>Gut Microbiota</condition>
  <condition>Fecal Metabolome</condition>
  <arm_group>
    <arm_group_label>probiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HOWARU Restore</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>microcrystalline cellulose</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HOWARU Restore</intervention_name>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_label>probiotic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy&#xD;
&#xD;
          -  aged 75 years or more&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals with chronic bowel diseases&#xD;
&#xD;
          -  Individuals with severe immunosuppression&#xD;
&#xD;
          -  Individuals with dementia&#xD;
&#xD;
          -  Individuals who are terminally ill&#xD;
&#xD;
          -  If severe/prolonged illness occurs after the start of the test, the subject must drop&#xD;
             out of the study&#xD;
&#xD;
          -  Individuals who have consumed probiotic products after two weeks prior to the start of&#xD;
             the study or during it.&#xD;
&#xD;
          -  Subjects with a history of substance abuse&#xD;
&#xD;
          -  Subjects that, in the investigators opinion, are not expected to complete the study&#xD;
             succesfully&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabriella C van Zanten, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Copenhagen, Dept. of Food Science</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Food Science, Food Microbiology, Faculty of Science, University of Copenhagen</name>
      <address>
        <city>Frederiksberg C</city>
        <zip>1958</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <study_first_submitted>July 31, 2014</study_first_submitted>
  <study_first_submitted_qc>August 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2014</study_first_posted>
  <last_update_submitted>June 20, 2016</last_update_submitted>
  <last_update_submitted_qc>June 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Gabriella C. van Zanten</investigator_full_name>
    <investigator_title>Postdoc</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

